IOSP vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IOSP presents as a financially stable, defensive value play with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet. While the stock trades almost exactly at its Graham Number ($74.99), suggesting fair defensive value, it trades at a significant premium to its growth-based intrinsic value ($32.69). The company demonstrates a strong track record of earnings beats, but this is offset by negative revenue growth and bearish insider sentiment. Overall, the lack of growth catalysts and poor long-term price performance temper the appeal of its strong solvency.
NEM shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics. Price trades at a 155.7% premium to fair value estimate ($44.73), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
IOSP vs NEM: Head-to-Head Comparison
This page compares Innospec Inc. (IOSP) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.